RE: Tired of this...3 Aug 2021 11:02
Disputing your version of events is neither being a liar or a bully I base my 10 million prediction on this segment of an Rns
For the five months ended 31 May 2021, the Company had unaudited sales of £88.4m compared to £40.8m for the same period in 2020. This £88.4m includes £40.7m of sales to the DHSC, which are part of the dispute. Excluding the DHSC, the Company saw a run-rate of over £10m in sales per month in Q1 2021, which has declined to approximately £7m per month in April and May as infection rates eased and testing has dropped sharply. This is a repeat of the trend seen in 2020 as countries moved into the summer period and the spread of COVID-19 declined.
Looking forward, the Company expects strong growth in private testing as markets and travel re-open, which could lead to higher infection rates, and an increase in testing to return in Q4 2021, in line with Q4 2020, during the winter period. The Company also expects to see significant new growth from the launch of new products during the second half of 2021, including an expansion of its lateral flow antigen testing portfolio for both professional and home use. If demand picks up in line with expectations, the Company expects to see full year sales of approximately £100m, excluding the sales to the DHSC which are in dispute.
Now would you agree testing has increased significantly? Now would you agree we are in approximately 25% of Fit2fly? For example gosafe expanding as pointed out by kaeren this morning biograd expanding as recently reported, I could go on but I don't need to happy with my investment, your not sell your mythical shares.
Sign In
Follow the stocks
